Ā | Uncomplicated group (Nā=ā48) | Complicated group (Nā=ā218) | p value |
---|---|---|---|
Median age (IQR) | 41 (31ā60) | 80 (69ā88) | ā<ā0.0001* |
Female sex | 48 (100%) | 139 (63.8%) | ā<ā0.001* |
Performance status | Ā | Ā | Ā |
Ā Ā 0ā2 | 48 (100%) | 144 (66.0%) | ā<ā0.001* |
Ā Ā 3ā4 (in bed more than 50%) | 0 | 74 (33.9%) | ā<ā0.001* |
Living place before admission | Ā | Ā | Ā |
Ā Ā Home | 48 (100%) | 156 (71.6%) | ā<ā0.001* |
Ā Ā Nursing facility or hospital | 0 | 62 (28.4%) | ā<ā0.001* |
Symptom duration days (IQR) | 2 (1ā3) | 1 (0ā2) | 0.0065* |
Bladder inflammatory symptoms | 36 (75.0%) | 73 (33.5%) | ā<ā0.001* |
Shaking chills | 35 (72.9%) | 85 (39.0%) | ā<ā0.001* |
Physical examinations | Ā | Ā | Ā |
Ā Ā CVA tenderness | 38 (79.2%) | 46 (21.1%) | ā<ā0.001* |
Ā Ā Bimanual palpation | 38 (79.2%) | 48 (22.0%) | ā<ā0.001* |
Ā Ā Prostate tenderness | 0 | 20 (27.8%) | 0.029* |
Catecholamine support needed | 1 (2.1%) | 7 (3.2%) | 1.000 |
Urinalysis | Ā | Ā | Ā |
Ā Ā Pyuria | 46 (95.8%) | 215 (99.1%) | 0.15 |
Ā Ā Bacteriuria | 47 (97.9%) | 212 (97.7%) | 0.70 |
Urine PCGS | Ā | Ā | Ā |
Ā Ā Pyuria | 48 (100%) | 215 (98.6%) | 0.55 |
Ā Ā Bacteriuria | 45 (93.8%) | 213 (97.7%) | 0.16 |
Urine culture results | Escherichia coli 44 | Escherichia coli 157 | Ā |
Ā | Enterobacter aerogenes 3 | Klebsiella spp. 24 | Ā |
Ā | Streptococcus spp. 2 | Pseudomonas aeruginosa 12 | Ā |
Ā | Nonpathogenic 1 | Citrobacter spp. 11 | Ā |
Ā | Ā | Streptococcus spp. 11 | Ā |
Ā | Ā | Proteus mirabilis 9 | Ā |
Ā | Ā | Enterococcus faecalis 6 | Ā |
Ā | Ā | Morganella morganeii 6 | Ā |
Ā | Ā | Serratia marcescens 4 | Ā |
Ā | Ā | Others 10 | Ā |
Ā | Ā | Nonpathogenic 11 | Ā |
Ā | Ā | Negative 1 | Ā |
Blood culture positivity | 8 (16.7%) | 67 (30.7%) | 0.053 |
Blood culture results | Escherichia coli 8 | Escherichia coli 57 | Ā |
Ā | Ā | Klebsiella spp. 5 | Ā |
Ā | Ā | Enterococcus spp. 2 | Ā |
Ā | Ā | Others 6 | Ā |
Antimicrobial resistance | 1 (2.1%) | 32 (14.7%) | 0.014* |
Initial antibiotics | Ā | Ā | Ā |
Ā Ā Based on PCGS | 45 (93.8%) | 184 (84.4%) | 0.064 |
Ā Ā Based on previous cultures | 1 (2.1%) | 31 (14.2%) | 0.010* |
Ā Ā Empirical treatment | 2 (4.1%) | 3 (1.4%) | 0.22 |
Death | 0 | 2 (0.9%) | 0.51 |